Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Erolet P
- Development stage
- Unknown
- Lead developer
- Droplet Life Science
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Erolet P is an oral fixed-dose combination tablet developed by Droplet Life Science, containing etoricoxib and paracetamol (acetaminophen). It is indicated for the treatment of pain and inflammatory conditions, including osteoarthritis, rheumatoid arthritis, gouty arthritis, ankylosing spondylitis, and musculoskeletal pain. Etoricoxib is a selective cyclooxygenase-2 (COX-2) inhibitor that reduces the synthesis of pro-inflammatory prostaglandins. Paracetamol acts as a centrally acting analgesic and antipyretic, providing complementary pain relief through mechanisms that are not entirely defined but are thought to involve the central nervous system. As a combination therapy, Erolet P leverages the distinct pathways of its components to manage both acute and chronic inflammatory pain.
- Brand names
- Erolet P
- Other names
- etoricoxib + paracetamol
02
Targets
PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)
Beyond the preview
Go deeper on Erolet P.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Erolet P.